Estrogen-receptor status and response to chemotherapy in early and advanced breast cancer

@article{Bonadonna1980EstrogenreceptorSA,
  title={Estrogen-receptor status and response to chemotherapy in early and advanced breast cancer},
  author={Gianni Bonadonna and Pinuccia Valagussa and Gabriele Tancini and Giovanni Di Fronzo},
  journal={Cancer Chemotherapy and Pharmacology},
  year={1980},
  volume={4},
  pages={37-41}
}
The value of estrogen receptor (ER) status in the prediction of tumor response to combination chemotherapy was retrospectively analyzed in breast cancer patients selected for prospective controlled trials of chemotherapy (85 with advanced disease and 256 with operable tumors). All patients were previously untreated with either chemotherapy or endocrine therapy, and in all instances drug therapy was applied at the time of primary treatment. The ER status was considered positive in 54% of women… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 27 references

A randomized study oftwo and three drug regimens in relation with estrogen receptors in metastatic breast cancer

  • D Rosner, T Nemoto
  • Proc Am Assoc Cancer Res
  • 1979
1 Excerpt

Combined-modality approach in locally advanced breast cancer (T3b--T4)

  • M De Lena, R Zucali, +4 authors U Veronesi
  • Proc Am Assoc Cancer Res
  • 1979
1 Excerpt

Does estrogen receptor status have prognostic value for recurrence or chemotherapy response in breast cancer

  • R Hilf, ML Feldstein, SL Gibson, ED Savlov
  • Proc Am Soc Clin Oneol 20:298
  • 1979
1 Excerpt

Operable breast cancer with positive axillary nodes (N+): results of 6 vs 12 cycles of adjuvant CMF in premenopausal women

  • G Tancini, E Bajetta, S Marchini, P Valagussa, G Bonadonna, U Veronesi
  • Proc Am Assoc Cancer Res
  • 1979
1 Excerpt

The association between steroid hormone receptor status and the disease - free interval in breast cancer

  • JC Allegra, R Simon, ME Lippman
  • 1979

Similar Papers

Loading similar papers…